Cizzle Biotechnology Holdings Plc (CIZ.L)

1.7190 +0.0690 (+4.18%) As of 10:01AM BST. Market open.

Cizzle Biotechnology Holdings Plc

60 Gracechurch Street
6th Floor
London EC3V 0HR
United Kingdom
44 20 3934 6630
https://www.cizzlebiotechnology.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 4

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Allan John Syms	Executive Chairman	N/A	N/A	1956
Prof. Dawn Coverley	Founder, Chief Scientific Officer & Non-Executive Director	N/A	N/A	1965
Mr. Nigel R. Lee	Finance Director & Executive Director	N/A	N/A	1961
Mr. Morgan Williams	Head of Commercialisation for Yorkshire Cancer Research and Board Observer	N/A	N/A	N/A

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.

Description

Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.

Corporate governance

Cizzle Biotechnology Holdings Plc’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.